With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Molecular Regulation of CNS Involvement in Pediatric ALL||New York University School of Medicine / Iannis Aifantis, PhD||Innovation Grants||2008||New York|
|New Approaches to Neuroblastoma Therapy||Children's Hospital Los Angeles / Robert Seeger||Phase I/II Infrastructure Grants||2008||California|
|Parallel sequencing to identify the causes of childhood cancer||Baylor College of Medicine / Sharon Plon||Innovation Grants||2008||Texas|
|PI-3 kinase as a novel and attractive target in pediatric cancer and neuroblastoma||Emory University / Donald Durden||Innovation Grants||2008||Georgia|
|Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors||Children's Hospital Los Angeles / William May||Innovation Grants||2008||California|
|Reciprocal interactions between tumor killer dendritic cells and tumor-induced regulatory T lymphocytes||University of Arizona / Nicolas Larmonier, PhD||Young Investigator Grants||2008||Arizona|
|Self-Management of Cancer-Related Fatigue by Adolescents: Pilot Study of an Evidence Based Educational Resource.||Seattle Children's Hospital and Regional Medical Center / Catherine Fiona Macpherson||Nurse Researcher Grants||2008||Washington|
|Targeting HMGA1 in Pediatric T-cell Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Joelle Hillion, PhD||Young Investigator Grants||2008||Maryland|
|The role of immunogenetics in natural killer cell targeting of neuroblastoma||Memorial Sloan-Kettering Cancer Center / Katharine Hsu||Innovation Grants||2008||New York|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|